A Study to Assess the Effect of Maintenance Treatment With Rituximab Versus No Treatment in Participants With Progressive B-Cell Chronic Lymphocytic Leukemia (CLL)
Clinical trial NCT00718549 · COMPLETED
Trial details
- NCT number
- NCT00718549
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-21
- Primary completion
- 2015-09-14
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.